Re: New SEDAR page

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: New SEDAR page

in response to

New SEDAR page

jonzobot

posted on Aug 06, 2023 07:54AM

We have not seen Zenith's 4th quarter and annual audited financials of April 31, 2023, and MD&A. They have had the available capital from Exempt Distributions as reported in these past months to get it done on time if that is the main reason.